Intensive BP therapy protection short-lived: study
The beneficial effect of intensive blood pressure treatment on cardiovascular and all-cause mortality does not persist, according to a study in JAMA Cardiology.
Byron C Jaeger (PhD), from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues conducted a secondary analysis of a multicentre, randomised clinical trial involving patients aged 50 or older with hypertension and increased cardiovascular risk to examine the long-term effects of randomisation to intensive treatment.